Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SPDR Gold Trust (GLD) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

SPDR Gold TrustTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

SPDR Gold Trust vs Vir Biotechnology Inc. Common Stock — how do they compare? SPDR Gold Trust trades at $380.7 (market cap $141.50B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: SPDR Gold Trust is far larger — about 78.6× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 75 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

GLDVIR
Market Cap
$141.50B$1.80B
Volume
5,707,2511,782,836
52-Week High
$495.90$11.78
52-Week Low
$362.32$5.12
Typical Hold Time
75 Days0 Days
Sector
—Health
Enterprise Value
—$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SPDR Gold Trust

GLD, tracking the price of gold, trades at $381.67, down 0.13% amid broader pressure from rising Treasury yields and a strong U.S. dollar. Technical indicators show a bearish bias with moving averages signaling sell pressure, while oscillators are neutral. Recent news highlights gold's struggle to maintain gains despite weak economic data, with support near $380. The absence of traditional stock fundamentals like P/E or revenue metrics reflects its nature as a commodity-backed ETF.

The outlook for GLD remains challenged by macroeconomic headwinds, including potential Federal Reserve rate hikes and elevated yields, which dampen gold's appeal. However, persistent inflation and geopolitical risks offer hedging opportunities. Risks include further dollar strength and yield increases, while any dovish Fed pivot could catalyze a rebound. Investors should weigh gold's role as a diversifier against ongoing monetary policy uncertainty.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GLD
48% Buy52% Sell
Avg holding period · 75 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About SPDR Gold Trust

GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.

Read more on GLD →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →